Unmatched Expert Leadership
The strength of any organization can be ascertained by looking to its volunteer leadership. At CureSearch, we’ve created councils of experts at the top of their fields in science, industry and finance, and validation of a research project by our Scientific Review Committee speaks volumes in the global pediatric cancer arena. This unmatched level of expertise convenes all parties necessary in the equation of drug development, and offers a unique and sophisticated approach that will accelerate new treatments for the families who are counting on us.
Scientific Advisory Council
The CureSearch for Children’s Cancer Scientific Advisory Council was created in 2012 to develop and guide the organization’s scientific strategy, agenda, and grants program in a way that strengthened the value of our research outcomes by focusing on moving findings from the bench to the bedside as quickly as possible.
With the support of the Scientific Advisory Council, CureSearch funds laboratory research aimed at transcending research barriers and developing innovative research approaches to solve the field’s most challenging problems.
CureSearch Scientific Advisory committee members (click each for more info):
Industry Advisory Council
The CureSearch for Children’s Cancer Industry Advisory Council was created in 2016 to guide the organization’s Catapult Initiative. The council brings together industry leaders committed to pediatric oncology drug development. With the support of the Industry Advisory Council, CureSearch hopes to propel new treatments over the Valley of Death by facilitating collaboration between academic researchers and pharmaceutical companies, fostering and encouraging pediatric oncology drug development and clinical trials and accelerating commercialization of new therapies for children with cancer.
CureSearch Industry Advisory committee members (click each for more info):
Catapult Advisory Council
The CureSearch for Children’s Cancer Catapult Advisory Council was created in 2017 to support the strategic operation and development of the Catapult Impact Fund (CIF), a proposed pool of $100M to be used to advance new treatments for pediatric cancers into human clinical trials and eventual drug development.
The council convenes leaders in venture capital, private equity, investment and tech transfer all with a passion for CureSearch’s mission. Working with the Catapult Advisory Council, CureSearch plans to raise and support an evergreen pipeline of funding that will catapult the best research out of the laboratory and into commercialization, the point at which it actually reaches children.
CureSearch Catapult Advisory Council members (click each for more info):